The document discusses the evolving role of benzodiazepines in the treatment of anxiety disorders. It notes that while antidepressants are now considered first-line treatment, benzodiazepines are still commonly prescribed and provide advantages like rapid onset of action. Benzodiazepines are particularly useful for initial treatment during the lag period of antidepressants or for residual anxiety when combined with antidepressants. The document concludes that benzodiazepines remain an important treatment option for anxiety disorders despite being considered second-line.